Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank79
3Y CAGR+53.2%
5Y CAGR+4.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+53.2%/yr
vs -16.7%/yr prior
5Y CAGR
+4.6%/yr
Recent acceleration
Acceleration
+69.9pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $40.79M | -10.9% |
| 2024 | $45.79M | +29.2% |
| 2023 | $35.44M | +212.1% |
| 2022 | $11.36M | -79.6% |
| 2021 | $55.74M | +71.1% |
| 2020 | $32.59M | +243.1% |
| 2019 | $9.50M | -59.7% |
| 2018 | $23.59M | -36.0% |
| 2017 | $36.84M | +66.8% |
| 2016 | $22.09M | - |